Tatjana Terzic is a Full Professor, Hematopathologist at Institute of Pathology, Faculty of Medicine University of Belgrade. She earned her MD from Faculty of Medicine University of Belgrade, MSc in Immunology and a PhD degree in Pathology at the University of Belgrade. Her career has focused on diagnostic hematopathology and teaching (twenty three years of teaching basic and clinical pathology to students, residents and a hematopathology fellows in the Medical Faculty, both studies in Serbian and in English; teaching at the postgraduated studies: Pathology, Hematology, Radiology and Oncology, Faculty of Medicine University of Belgrade). Her research interest focuses on pathophysiology of tumours, detection of target therapeutical molecules, molecular pathology of tumours, especially pathology of lymphoma, myeloproliferative neoplasm and cancer immunology. The studies involve both basic research and clinical application. The studies are funded by the Serbian Ministry of Science. She is member of European Association for Hematopathology, European Society of Pathology, the European Society for Pediatric Oncology, Serbian Pathology and Cytology Association and Serbian Medical Society. She has authored numerous original research articles and has made invited presentations at national and international conferences and courses.
Tatjana Terzic is a Full Professor, Hematopathologist at Institute of Pathology, Faculty of Medicine University of Belgrade. She earned her MD from Faculty of Medicine University of Belgrade, MSc in Immunology and a PhD degree in Pathology at the University of Belgrade. Her career has focused on diagnostic hematopathology and teaching (twenty three years of teaching basic and clinical pathology to students, residents and a hematopathology fellows in the Medical Faculty, both studies in Serbian and in English; teaching at the postgraduated studies: Pathology, Hematology, Radiology and Oncology, Faculty of Medicine University of Belgrade). Her research interest focuses on pathophysiology of tumours, detection of target therapeutical molecules, molecular pathology of tumours, especially pathology of lymphoma, myeloproliferative neoplasm and cancer immunology. The studies involve both basic research and clinical application. The studies are funded by the Serbian Ministry of Science. She is member of European Association for Hematopathology, European Society of Pathology, the European Society for Pediatric Oncology, Serbian Pathology and Cytology Association and Serbian Medical Society. She has authored numerous original research articles and has made invited presentations at national and international conferences and courses.